Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=icnv20 Cancer Investigation ISSN: 0735-7907 (Print) 1532-4192 (Online) Journal homepage: http://www.tandfonline.com/loi/icnv20 Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan Anders Toft, Thomas Urup, Ib Jarle Christensen, Signe Regner Michaelsen, Babloo Lukram, Kirsten Grunnet, Michael Kosteljanetz, Vibeke Andrée Larsen, Ulrik Lassen, Helle Broholm & Hans Skovgaard Poulsen To cite this article: Anders Toft, Thomas Urup, Ib Jarle Christensen, Signe Regner Michaelsen, Babloo Lukram, Kirsten Grunnet, Michael Kosteljanetz, Vibeke Andrée Larsen, Ulrik Lassen, Helle Broholm & Hans Skovgaard Poulsen (2018): Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan, Cancer Investigation, DOI: 10.1080/07357907.2018.1430818 To link to this article: https://doi.org/10.1080/07357907.2018.1430818 View supplementary material Published online: 02 Feb 2018. Submit your article to this journal View related articles View Crossmark data